EUVIMEDEUVIMED entdecken
Querschnittstudie

Study of serum microRNA-217 expression pattern in different stages of Diabetic Kidney Disease - a cross-sectional study

Ponnudhali D, Lakshmiprabha S, Priya K Dhas, Nagarajan P

Journal of Clinical Medicine of Kazakhstan · 09.03.2026

DOI: 10.23950/jcmk/18054 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Clinical Medicine of Kazakhstan, erschienen am 09.03.2026. Verfasst von Ponnudhali D und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic kidney disease (DKD) represents the leading cause of end-stage renal disease worldwide, affecting 30-40% of patients with type 2 diabetes mellitus (T2DM). Some microRNAs (miRNAs), like miRNA-217 are upregulated in Diabetic Kidney Disease (DKD), and known to play a key role in Diabetes Mellitus & its complications. Recent studies have shown miRNA 217 to be involved in the development of DKD,  by promoting renal inflammation, angiogenesis and fibrosis.



Aim & objectives: To assess the miR217 expression levels in DKD patients with differing stages of albuminuria, compared to normoalbuminuric Diabetes mellitus -II patients & to identify its role as a predictive biomarker of DKD.



Methodology: This analytical cross-sectional study recruited 135 participants aged 40-65 years from a Govt medical college Hospital in Tamil Nadu. Participants includedT2DM patients (n=34) & DKD patients & healthy controls(n=35). Fasting serum samples were collected & miRNA-217 extraction and qRT-PCR quantification was done & Fold change was calculated, along with the baseline clinical parameters (age, BMI, HbA1c, lipids, urea, creatinine, eGFR, UACR).

Statistical analyses like Kruskal-Wallis tests, Spearman's correlations & ROC curves were computed using Jamovi software version 2.6.44



Results: Serum miRNA-217 expression was markedly elevated in DKD patients with microalbuminuria (39.36 ± 76.24 fold change) & macroalbuminuria (64.32 ± 109.23 fold change) compared to Diabetes mellitus -II patients with normoalbuminuria (2.29 ± 4.77, P=0.027).MiRNA-217 correlated positively with UACR (ρ=0.472, p<0.001) and was able to discriminate DKD from Diabetes-II, with 59% sensitivity & 90% specificity,  ROC analysis yielded AUC 0.738 (p<0.001).

Conclusion

Serum miRNA-217 exhibits progressive up-regulation in accordance with stages of DKD severity, with moderate diagnostic utility. miRNA-217 could be a potential biomarker for early DKD detection and risk stratification, warranting longitudinal studies in larger populations for further validation and establishment of these findings.

Zitieren

APA

D, P., S, L., Dhas, P. K., & P, N. (2026). Study of serum microRNA-217 expression pattern in different stages of Diabetic Kidney Disease - a cross-sectional study. Journal of Clinical Medicine of Kazakhstan. https://doi.org/10.23950/jcmk/18054

Vancouver

D P, S L, Dhas PK, P N. Study of serum microRNA-217 expression pattern in different stages of Diabetic Kidney Disease - a cross-sectional study. Journal of Clinical Medicine of Kazakhstan. 2026. doi:10.23950/jcmk/18054

BibTeX
@article{D2026,
  author = {D, Ponnudhali and S, Lakshmiprabha and Dhas, Priya K and P, Nagarajan},
  title = {Study of serum microRNA-217 expression pattern in different stages of Diabetic Kidney Disease - a cross-sectional study},
  journal = {Journal of Clinical Medicine of Kazakhstan},
  year = {2026},
  doi = {10.23950/jcmk/18054}
}
Kostenlos starten →